Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 22 studies | 46% ± 22% | |
CD16-negative, CD56-bright natural killer cell, human | 15 studies | 60% ± 18% | |
CD8-positive, alpha-beta T cell | 11 studies | 26% ± 6% | |
innate lymphoid cell | 8 studies | 53% ± 21% | |
mature NK T cell | 8 studies | 46% ± 21% | |
gamma-delta T cell | 7 studies | 46% ± 11% | |
T cell | 5 studies | 21% ± 4% | |
CD8-positive, alpha-beta memory T cell | 4 studies | 23% ± 6% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 47% ± 17% | |
group 3 innate lymphoid cell | 3 studies | 46% ± 16% |
Insufficient scRNA-seq data for expression of XCL1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 98% | 66.55 | 566 / 578 | 81% | 5.04 | 930 / 1155 |
uterus | 90% | 17.66 | 153 / 170 | 69% | 5.07 | 315 / 459 |
esophagus | 77% | 14.16 | 1111 / 1445 | 70% | 4.10 | 128 / 183 |
thymus | 86% | 23.62 | 562 / 653 | 51% | 3.05 | 309 / 605 |
kidney | 76% | 15.42 | 68 / 89 | 56% | 2.17 | 509 / 901 |
stomach | 85% | 19.51 | 305 / 359 | 46% | 1.54 | 132 / 286 |
liver | 87% | 38.23 | 197 / 226 | 43% | 1.69 | 175 / 406 |
breast | 76% | 18.15 | 350 / 459 | 52% | 1.63 | 577 / 1118 |
bladder | 57% | 23.48 | 12 / 21 | 67% | 5.08 | 338 / 504 |
intestine | 84% | 24.73 | 815 / 966 | 35% | 1.19 | 183 / 527 |
ovary | 46% | 6.07 | 82 / 180 | 72% | 3.67 | 311 / 430 |
prostate | 82% | 15.84 | 202 / 245 | 26% | 0.52 | 133 / 502 |
spleen | 100% | 236.13 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.98 | 1 / 1 |
skin | 40% | 4.82 | 724 / 1809 | 54% | 2.32 | 255 / 472 |
peripheral blood | 90% | 188.20 | 834 / 929 | 0% | 0 | 0 / 0 |
pancreas | 39% | 3.98 | 127 / 328 | 50% | 1.59 | 89 / 178 |
lymph node | 0% | 0 | 0 / 0 | 86% | 17.08 | 25 / 29 |
tonsil | 0% | 0 | 0 / 0 | 82% | 2.88 | 37 / 45 |
adipose | 82% | 23.51 | 983 / 1204 | 0% | 0 | 0 / 0 |
heart | 67% | 11.70 | 573 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 63% | 15.54 | 841 / 1335 | 0% | 0 | 0 / 0 |
brain | 47% | 5.57 | 1230 / 2642 | 5% | 0.10 | 33 / 705 |
adrenal gland | 30% | 2.59 | 77 / 258 | 9% | 0.23 | 21 / 230 |
eye | 0% | 0 | 0 / 0 | 13% | 0.42 | 10 / 80 |
muscle | 6% | 0.52 | 49 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002826 | Biological process | negative regulation of T-helper 1 type immune response |
GO_0071636 | Biological process | positive regulation of transforming growth factor beta production |
GO_0002726 | Biological process | positive regulation of T cell cytokine production |
GO_0071560 | Biological process | cellular response to transforming growth factor beta stimulus |
GO_2000556 | Biological process | positive regulation of T-helper 1 cell cytokine production |
GO_0006954 | Biological process | inflammatory response |
GO_0002725 | Biological process | negative regulation of T cell cytokine production |
GO_0032703 | Biological process | negative regulation of interleukin-2 production |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0071663 | Biological process | positive regulation of granzyme B production |
GO_0007165 | Biological process | signal transduction |
GO_0009615 | Biological process | response to virus |
GO_0010820 | Biological process | positive regulation of T cell chemotaxis |
GO_0030593 | Biological process | neutrophil chemotaxis |
GO_0032733 | Biological process | positive regulation of interleukin-10 production |
GO_0051209 | Biological process | release of sequestered calcium ion into cytosol |
GO_2000518 | Biological process | negative regulation of T-helper 1 cell activation |
GO_0050727 | Biological process | regulation of inflammatory response |
GO_0071353 | Biological process | cellular response to interleukin-4 |
GO_0035782 | Biological process | mature natural killer cell chemotaxis |
GO_0043433 | Biological process | negative regulation of DNA-binding transcription factor activity |
GO_2000553 | Biological process | positive regulation of T-helper 2 cell cytokine production |
GO_0007267 | Biological process | cell-cell signaling |
GO_2000538 | Biological process | positive regulation of B cell chemotaxis |
GO_0001916 | Biological process | positive regulation of T cell mediated cytotoxicity |
GO_0070098 | Biological process | chemokine-mediated signaling pathway |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_2000563 | Biological process | positive regulation of CD4-positive, alpha-beta T cell proliferation |
GO_2000503 | Biological process | positive regulation of natural killer cell chemotaxis |
GO_0048245 | Biological process | eosinophil chemotaxis |
GO_2000566 | Biological process | positive regulation of CD8-positive, alpha-beta T cell proliferation |
GO_0090023 | Biological process | positive regulation of neutrophil chemotaxis |
GO_0051281 | Biological process | positive regulation of release of sequestered calcium ion into cytosol |
GO_0032689 | Biological process | negative regulation of type II interferon production |
GO_2000513 | Biological process | positive regulation of granzyme A production |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_2000558 | Biological process | positive regulation of immunoglobulin production in mucosal tissue |
GO_2000412 | Biological process | positive regulation of thymocyte migration |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0002690 | Biological process | positive regulation of leukocyte chemotaxis |
GO_2000562 | Biological process | negative regulation of CD4-positive, alpha-beta T cell proliferation |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0008009 | Molecular function | chemokine activity |
GO_0048020 | Molecular function | CCR chemokine receptor binding |
GO_0042379 | Molecular function | chemokine receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | XCL1 |
Protein name | Lymphotactin (ATAC) (C motif chemokine 1) (Cytokine SCM-1) (Lymphotaxin) (SCM-1-alpha) (Small-inducible cytokine C1) (XC chemokine ligand 1) |
Synonyms | LTN SCYC1 |
Description | FUNCTION: Chemotactic activity for lymphocytes but not for monocytes or neutrophils. In thymus, mediates medullary accumulation of thymic dendritic cells and contributes to regulatoy T cell development, playing a role in self-tolerance establishment. . |
Accessions | ENST00000367818.4 P47992 |